COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2025
09/07/2025
Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
GUERBET : Bilan semestriel du contrat de liquidité
09/07/2025
Bilan semestriel du contrat de liquidité Villepinte, le 9 juillet 2025 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, présente aujourd’hui le bilan [...]
Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country
09/07/2025
Recurring order from an undisclosed European country to strengthen public preparedness. Combined with other recent orders from non-European countries, the Company has now secured above DKK 3,000 million in contracts in [...]
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
09/07/2025
RIYADH, Saudi Arabia, July 09, 2025 (GLOBE NEWSWIRE) -- In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has [...]
FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer
09/07/2025
LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]
FDA Clears Updated Magstim Rapid Transcranial Magnetic Stimulation Research System
09/07/2025
Top-Cited TMS Brain Research Technology Enhanced for Next-Generation Neuromodulation MINNEAPOLIS, July 09, 2025 (GLOBE NEWSWIRE) -- The FDA has cleared the new Magstim Rapid TMS system for research and clinical [...]
INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
09/07/2025
SARASOTA, Fla., July 09, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility market, today announced further efforts to drive [...]
Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China
09/07/2025
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care [...]
Dandy Launches America’s First Two-Visit Dentures for Medicaid, Medicare, and Low-Paying PPOs
09/07/2025
Top-quality dentures. Affordable by design. Delivered in two appointments NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Dandy , America’s fully digital dental lab, today announced the first premium denture solution priced [...]
Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors
09/07/2025
Veteran clinical leader with successful track record and experience to help guide the Company’s clinical strategy in Fibrostenotic Crohn’s Disease and Ulcerative Colitis Carlsbad, CA, July 09, 2025 (GLOBE NEWSWIRE) -- [...]
Qanatpharma, Zuse Institute Berlin, Enamine, and Proteros biostructures Announce Generative-AI Driven Lead Discovery Collaboration
09/07/2025
Joint research program targets new treatments for life-threatening complication of brain hemorrhage An international discovery collaboration is harnessing AI-powered drug discovery to develop a first-in-class therapy to [...]
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
09/07/2025
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts trial profile [...]
Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines
09/07/2025
Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery System; Company is Currently Conducting Additional Studies into New and Previously Untested KRAS [...]
Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045
09/07/2025
Application Update Based on Extensive Review of Data GLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company [...]
Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements
09/07/2025
NEWTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for [...]
Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law
09/07/2025
Fountain Life operates four flagship longevity centers, including two in Florida, where a new state law effective July 1, 2025, authorizes licensed physicians to administer stem cell therapies to members with conditions [...]
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes
09/07/2025
Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of Sernova’s Phase 1/2 Cell Pouch Bio-hybrid Organ Clinical Trial in Patients with Type 1 Diabetes LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova [...]
Ernexa Therapeutics Regains Compliance with Nasdaq Listing Requirements
09/07/2025
CAMBRIDGE, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that it has [...]
Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies
09/07/2025
Phase 1/2 clinical study evaluating seclidemstat in patients with MDS and CMML is progressing with updates expected later this year Company continues to advance its contemplated merger with Decoy Therapeutics HOUSTON, [...]

Pages